Cargando…
A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients
Liver fibrosis must be evaluated in patients with hepatitis C virus (HCV) after liver transplantation because its severity affects their prognosis and the recurrence of HCV. Since invasive biopsy is still the gold standard to identify patients at risk of graft loss from rapid fibrosis progression, i...
Autores principales: | Cano, Ainara, Mariño, Zoe, Millet, Oscar, Martínez-Arranz, Ibon, Navasa, Miquel, Falcón-Pérez, Juan Manuel, Pérez-Cormenzana, Miriam, Caballería, Joan, Embade, Nieves, Forns, Xavier, Bosch, Jaume, Castro, Azucena, Mato, José María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585246/ https://www.ncbi.nlm.nih.gov/pubmed/28874799 http://dx.doi.org/10.1038/s41598-017-10807-y |
Ejemplares similares
-
Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum (1)H-NMR Spectroscopy
por: Embade, Nieves, et al.
Publicado: (2016) -
Data in support of enhancing metabolomics research through data mining
por: Martínez-Arranz, Ibon, et al.
Publicado: (2015) -
Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19
por: Bruzzone, Chiara, et al.
Publicado: (2023) -
Inmunosupresión en el trasplante hepático en la era covid-19
por: Forns, Xavier, et al.
Publicado: (2020) -
Liver transplant immunosuppression during the COVID-19 pandemic()
por: Forns, Xavier, et al.
Publicado: (2020)